{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:52:38Z","timestamp":1791442358502,"version":"4.3.3"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG056478, AG044897"],"award-info":[{"award-number":["AG056478, AG044897"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00701","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T04:17:18Z","timestamp":1513657038000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":158,"title":["Optical Coherence Tomography in Alzheimer\u2019s Disease and Other Neurodegenerative Diseases"],"prefix":"10.3389","volume":"8","author":[{"given":"Jonah","family":"Doustar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Torbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/wsbm.22","article-title":"Vertebrate retina and hypothalamus development","volume":"1","author":"Byerly","year":"2009","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"B2","volume-title":"The Retina","author":"Purves","year":"2001"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fncel.2016.00020","article-title":"Brain and retinal pericytes: origin, function and role","volume":"10","author":"Trost","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10707","DOI":"10.1523\/JNEUROSCI.1711-16.2016","article-title":"Reconnecting eye to brain","volume":"36","author":"Crair","year":"2016","journal-title":"J Neurosci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer\u2019s disease facts and figures","volume":"12","author":"Alzheimer\u2019s","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.ncl.2016.06.009","article-title":"Alzheimer disease and its growing epidemic: risk factors, biomarkers, and the urgent need for therapeutics","volume":"34","author":"Hickman","year":"2016","journal-title":"Neurol Clin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0002-9394(87)90001-8","article-title":"Assessment of visual impairment in patients with Alzheimer\u2019s disease","volume":"104","author":"Sadun","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnagi.2016.00078","article-title":"The association between obstructive sleep apnea and Alzheimer\u2019s disease: a meta-analysis perspective","volume":"8","author":"Emamian","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaneurol.2013.2334","article-title":"Sleep quality and preclinical Alzheimer disease","volume":"70","author":"Ju","year":"2013","journal-title":"JAMA Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2165\/00023210-200115100-00004","article-title":"Sleep disturbances in patients with Alzheimer\u2019s disease: epidemiology, pathophysiology and treatment","volume":"15","author":"Vitiello","year":"2001","journal-title":"CNS Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","article-title":"Amyloid biomarkers in Alzheimer\u2019s disease","volume":"36","author":"Blennow","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer\u2019s: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awp068","article-title":"The retina in Parkinson\u2019s disease","volume":"132","author":"Archibald","year":"2009","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.eye.6700729","article-title":"Optical coherence tomography \u2013 a review of the principles and contemporary uses in retinal investigation","volume":"18","author":"Thomas","year":"2004","journal-title":"Eye (Lond)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/1469-8986.00055","article-title":"Optical coherence tomography: technology and applications for neuroimaging","volume":"40","author":"Boppart","year":"2003","journal-title":"Psychophysiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2013.4","article-title":"Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients","volume":"27","author":"Satue","year":"2013","journal-title":"Eye (Lond)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.neurol.2010.03.024","article-title":"Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis","volume":"166","author":"Lamirel","year":"2010","journal-title":"Rev Neurol (Paris)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0134750","DOI":"10.1371\/journal.pone.0134750","article-title":"Optical coherence tomography in Alzheimer\u2019s disease: a meta-analysis","volume":"10","author":"Coppola","year":"2015","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ajo.2008.06.010","article-title":"Thickness profiles of retinal layers by optical coherence tomography image segmentation","volume":"146","author":"Bagci","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.preteyeres.2006.03.001","article-title":"Retinal assessment using optical coherence tomography","volume":"25","author":"Costa","year":"2006","journal-title":"Prog Retin Eye Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1167\/iovs.08-2113","article-title":"Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema","volume":"49","author":"Forooghian","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/bjo.2008.137356","article-title":"Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration","volume":"93","author":"Yi","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"ii:93621","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease","volume":"2","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"1","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","article-title":"Melanopsin retinal ganglion cell loss in Alzheimer disease","volume":"79","author":"La Morgia","year":"2016","journal-title":"Ann Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","article-title":"alpha-Synuclein in the inner retina in Parkinson disease","volume":"75","author":"Bodis-Wollner","year":"2014","journal-title":"Ann Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jalz.2015.08.166","article-title":"Individual estimates of age at detectable amyloid onset for risk factor assessment","volume":"12","author":"Bilgel","year":"2016","journal-title":"Alzheimers Dement"},{"key":"B31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s00415-014-7374-z","article-title":"Retinal alterations in mild cognitive impairment and Alzheimer\u2019s disease: an optical coherence tomography study","volume":"261","author":"Ascaso","year":"2014","journal-title":"J Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","article-title":"Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"45","author":"Cheung","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40942-016-0049-4","article-title":"The role of optical coherence tomography in Alzheimer\u2019s disease","volume":"2","author":"Cunha","year":"2016","journal-title":"Int J Retina Vitreous"},{"key":"B35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","article-title":"Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"6","author":"den Haan","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.dadm.2015.01.004","article-title":"Retinal blood flow in mild cognitive impairment and Alzheimer\u2019s disease","volume":"1","author":"Feke","year":"2015","journal-title":"Alzheimer Dement"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3233\/JAD-160886","article-title":"Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer\u2019s disease","volume":"56","author":"Ferrari","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","article-title":"Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"60","author":"Gao","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0007114515004687","article-title":"Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer\u2019s disease","volume":"115","author":"Goozee","year":"2016","journal-title":"Br J Nutr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/jnnp-2011-301628","article-title":"Retinal pathology as biomarker for cognitive impairment and Alzheimer\u2019s disease","volume":"83","author":"Ikram","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.clineuro.2011.02.014","article-title":"Retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"113","author":"Kesler","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12883-015-0268-6","article-title":"Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10072-014-2055-3","article-title":"The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness","volume":"36","author":"Oktem","year":"2015","journal-title":"Neurol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","article-title":"Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"420","author":"Paquet","year":"2007","journal-title":"Neurosci Lett"},{"key":"B45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/1533317515628053","article-title":"Retinal nerve fiber layer thinning in Alzheimer\u2019s disease: a case-control study in comparison to normal aging, Parkinson\u2019s disease, and non-Alzheimer\u2019s dementia","volume":"31","author":"Pillai","year":"2016","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"B46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1567205011666140131114418","article-title":"Retinal nerve fiber layer thickness is associated with episodic memory deficit in mild cognitive impairment patients","volume":"11","author":"Shen","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-131898","article-title":"Greater attenuation of retinal nerve fiber layer thickness in Alzheimer\u2019s disease patients","volume":"40","author":"Shi","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.dadm.2016.09.001","article-title":"Nonvascular retinal imaging markers of preclinical Alzheimer\u2019s disease","volume":"4","author":"Snyder","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.dadm.2015.03.001","article-title":"A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography","volume":"1","author":"Thomson","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neulet.2016.07.006","article-title":"Retinal nerve fibre layer thickness changes in Alzheimer\u2019s disease: results from a 12-month prospective case series","volume":"629","author":"Trebbastoni","year":"2016","journal-title":"Neurosci Lett"},{"key":"B51","doi-asserted-by":"publisher","first-page":"793931","DOI":"10.4061\/2010\/793931","article-title":"Alzheimer\u2019s disease and glaucoma: imaging the biomarkers of neurodegenerative disease","volume":"2010","author":"Valenti","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","article-title":"Optic-nerve degeneration in Alzheimer\u2019s disease","volume":"315","author":"Hinton","year":"1986","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","article-title":"Retinal ganglion cell degeneration in Alzheimer\u2019s disease","volume":"501","author":"Blanks","year":"1989","journal-title":"Brain Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0161-6420(90)32621-0","article-title":"Optic nerve damage in Alzheimer\u2019s disease","volume":"97","author":"Sadun","year":"1990","journal-title":"Ophthalmology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0197-4580(96)00009-7","article-title":"Retinal pathology in Alzheimer\u2019s disease. I. Ganglion cell loss in foveal\/parafoveal retina","volume":"17","author":"Blanks","year":"1996","journal-title":"Neurobiol Aging"},{"key":"B56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","article-title":"Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL","volume":"17","author":"Blanks","year":"1996","journal-title":"Neurobiol Aging"},{"key":"B57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0420.1996.tb00090.x","article-title":"Retinal nerve fiber layer abnormalities in Alzheimer\u2019s disease","volume":"74","author":"Hedges","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"B58","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/opo.12220","article-title":"Oculo-visual changes and clinical considerations affecting older patients with dementia","volume":"35","author":"Armstrong","year":"2015","journal-title":"Ophthalmic Physiol Opt"},{"key":"B59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-150457","article-title":"Retinal oximetry imaging in Alzheimer\u2019s disease","volume":"49","author":"Einarsdottir","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1038\/tp.2012.150","article-title":"Retinal vascular biomarkers for early detection and monitoring of Alzheimer\u2019s disease","volume":"3","author":"Frost","year":"2013","journal-title":"Transl Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2010-100819","article-title":"Ocular biomarkers for early detection of Alzheimer\u2019s disease","volume":"22","author":"Frost","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"BIO227","DOI":"10.1167\/iovs.17-21776","article-title":"Retinal oximetry discovers novel biomarkers in retinal and brain diseases","volume":"58","author":"Stefansson","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archopht.1991.01080020045040","article-title":"Optic nerve head and nerve fiber layer in Alzheimer\u2019s disease","volume":"109","author":"Tsai","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.dadm.2015.04.001","article-title":"Retinal microvascular network attenuation in Alzheimer\u2019s disease","volume":"1","author":"Williams","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","article-title":"Retinal abnormalities in early Alzheimer\u2019s disease","volume":"48","author":"Berisha","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","article-title":"Microvascular network alterations in the retina of patients with Alzheimer\u2019s disease","volume":"10","author":"Cheung","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/S1388-2457(01)00620-4","article-title":"Morphological and functional retinal impairment in Alzheimer\u2019s disease patients","volume":"112","author":"Parisi","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fpsyt.2014.00022","article-title":"Detection of retinal nerve fiber layer defects in Alzheimer\u2019s disease using SD-OCT","volume":"5","author":"Kromer","year":"2014","journal-title":"Front Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1364\/BOE.8.000016","article-title":"Wide-field retinal optical coherence tomography with wavefront sensorless adaptive optics for enhanced imaging of targeted regions","volume":"8","author":"Polans","year":"2017","journal-title":"Biomed Opt Express"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/eye.2017.23","article-title":"Visual dysfunction and its correlation with retinal changes in patients with Alzheimer\u2019s disease","volume":"31","author":"Polo","year":"2017","journal-title":"Eye (Lond)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3906\/sag-1406-145","article-title":"Neurodegeneration in ocular and central nervous systems: optical coherence tomography study in normal-tension glaucoma and Alzheimer disease","volume":"45","author":"Eraslan","year":"2015","journal-title":"Turk J Med Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clineuro.2015.02.016","article-title":"Analysis of optic disk color changes in Alzheimer\u2019s disease: a potential new biomarker","volume":"132","author":"Bambo","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","article-title":"Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography","volume":"480","author":"Lu","year":"2010","journal-title":"Neurosci Lett"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0153830","DOI":"10.1371\/journal.pone.0153830","article-title":"Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer\u2019s disease","volume":"11","author":"Cunha","year":"2016","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3906\/sag-1405-114","article-title":"Evaluation of retinal nerve fiber layer thickness in Alzheimer disease using spectral-domain optical coherence tomography","volume":"45","author":"Gunes","year":"2015","journal-title":"Turk J Med Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-121975","article-title":"Retinal nerve fiber layer thinning in dementia associated with Parkinson\u2019s disease, dementia with Lewy bodies, and Alzheimer\u2019s disease","volume":"34","author":"Moreno-Ramos","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","article-title":"Retinal nerve fiber layer thickness in patients with Alzheimer disease","volume":"33","author":"Kirbas","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00417-017-3715-9","article-title":"OCT in Alzheimer\u2019s disease: thinning of the RNFL and superior hemiretina","volume":"255","author":"Cunha","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","article-title":"Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease","volume":"26","author":"Iseri","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"B80","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients","volume":"40","author":"Parisi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1167\/iovs.13-12046","article-title":"Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer\u2019s disease using spectral-domain optical coherence tomography","volume":"54","author":"Marziani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2174\/156720512802455340","article-title":"Structural and functional impairment of the retina and optic nerve in Alzheimer\u2019s disease","volume":"9","author":"Moschos","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"636548","DOI":"10.1155\/2015\/636548","article-title":"Analysis of retinal peripapillary segmentation in early Alzheimer\u2019s disease patients","volume":"2015","author":"Salobrar-Garcia","year":"2015","journal-title":"Biomed Res Int"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4172\/2324-8599.1000145","article-title":"Retinal examination for the diagnosis of Alzheimer\u2019s disease","volume":"3","author":"Kayabasi","year":"2014","journal-title":"Int J Ophthalmic Pathol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","article-title":"Correlation between retinal morphological and functional findings and clinical severity in Parkinson\u2019s disease","volume":"116","author":"Altintas","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1167\/iovs.16-20460","article-title":"Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson\u2019s disease","volume":"58","author":"Satue","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5301\/EJO.2010.1318","article-title":"Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss","volume":"21","author":"Moschos","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","article-title":"Retinal nerve fiber layer thinning in Parkinson disease","volume":"44","author":"Inzelberg","year":"2004","journal-title":"Vision Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"728457","DOI":"10.1155\/2012\/728457","article-title":"Interocular asymmetry of foveal thickness in Parkinson disease","volume":"2012","author":"Shrier","year":"2012","journal-title":"J Ophthalmol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","article-title":"Inner retinal layer thinning in Parkinson disease","volume":"127","author":"Hajee","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WNO.0b013e31828c4e1a","article-title":"Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease","volume":"33","author":"Adam","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-132039","article-title":"Choroidal thinning as a new finding in Alzheimer\u2019s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography","volume":"40","author":"Gharbiya","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/08820530390897855","article-title":"Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer\u2019s disease","volume":"18","author":"Parisi","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/geronj\/49.2.P52","article-title":"Motion perception and Alzheimer\u2019s disease","volume":"49","author":"Gilmore","year":"1994","journal-title":"J Gerontol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","article-title":"Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease","volume":"22","author":"Alexandrov","year":"2011","journal-title":"Neuroreport"},{"key":"B96","first-page":"24","article-title":"Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina","volume":"36","author":"Loffler","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e53547","DOI":"10.1371\/journal.pone.0053547","article-title":"Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice","volume":"7","author":"Schon","year":"2012","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1167\/iovs.13-12888","article-title":"Ocular changes in TgF344-AD rat model of Alzheimer\u2019s disease","volume":"55","author":"Tsai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fneur.2017.00162","article-title":"Retinal ganglion cells and circadian rhythms in Alzheimer\u2019s disease, Parkinson\u2019s disease, and beyond","volume":"8","author":"La Morgia","year":"2017","journal-title":"Front Neurol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jalz.2013.06.004","article-title":"Alzheimer\u2019s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers","volume":"10","author":"Chang","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e0135499","DOI":"10.1371\/journal.pone.0135499","article-title":"Alzheimer\u2019s disease-related protein expression in the retina of Octodon degus","volume":"10","author":"Du","year":"2015","journal-title":"PLoS One"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00417-009-1060-3","article-title":"Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer\u2019s disease","volume":"247","author":"Dutescu","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2016.04.059","article-title":"Amyloid beta accumulation and inner retinal degenerative changes in Alzheimer\u2019s disease transgenic mouse","volume":"623","author":"Gupta","year":"2016","journal-title":"Neurosci Lett"},{"key":"B104","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000335154","article-title":"Alzheimer\u2019s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment","volume":"10","author":"Koronyo","year":"2012","journal-title":"Neurodegener Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2353\/ajpath.2009.090159","article-title":"Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer\u2019s transgenic mice","volume":"175","author":"Liu","year":"2009","journal-title":"Am J Pathol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1167\/iovs.08-1849","article-title":"Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease","volume":"49","author":"Ning","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.08-2384","article-title":"Beta-amyloid deposition and functional impairment in the retina of the APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease","volume":"50","author":"Perez","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1471-4159.2009.06402.x","article-title":"Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9","volume":"111","author":"Koronyo-Hamaoui","year":"2009","journal-title":"J Neurochem"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/brain\/awv150","article-title":"Therapeutic effects of glatiramer acetate and grafted CD115(+) monocytes in a mouse model of Alzheimer\u2019s disease","volume":"138","author":"Koronyo","year":"2015","journal-title":"Brain"},{"key":"B110","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2353\/ajpath.2010.090840","article-title":"Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer\u2019s disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow","volume":"177","author":"Keene","year":"2010","journal-title":"Am J Pathol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1742-2094-2-28","article-title":"Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer\u2019s disease","volume":"2","author":"Zhou","year":"2005","journal-title":"J Neuroinflammation"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e64246","DOI":"10.1371\/journal.pone.0064246","article-title":"Suppressed retinal degeneration in aged wild type and APPswe\/PS1DeltaE9 mice by bone marrow transplantation","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/WCO.0b013e328334e99b","article-title":"Optical coherence tomography of the retina: applications in neurology","volume":"23","author":"Jindahra","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1167\/iovs.13-13629","article-title":"Potential new diagnostic tool for Alzheimer\u2019s disease using a linear discriminant function for Fourier domain optical coherence tomography","volume":"55","author":"Larrosa","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00417-016-3430-y","article-title":"Alzheimer\u2019s disease: a review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo","volume":"254","author":"Cunha","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/eye.2014.51","article-title":"Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer\u2019s disease","volume":"28","author":"Polo","year":"2014","journal-title":"Eye (Lond)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","article-title":"NEURODEGENERATION. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (Lond)"},{"key":"B119","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/brain\/101.4.661","article-title":"Measurements of visual evoked potentials in Parkinson\u2019s disease","volume":"101","author":"Bodis-Wollner","year":"1978","journal-title":"Brain"},{"key":"B121","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000439252","article-title":"Higher frequency and complexity of sleep disturbances in dementia with Lewy bodies as compared to Alzheimer\u2019s disease","volume":"16","author":"Chwiszczuk","year":"2016","journal-title":"Neurodegener Dis"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820538.2017.1307423","article-title":"Evaluation of choroidal and retinal thickness changes in Parkinson\u2019s disease using spectral domain optical coherence tomography","author":"Moschos","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/mds.23215","article-title":"Retina thickness in Parkinson\u2019s disease and essential tremor","volume":"25","author":"Cubo","year":"2010","journal-title":"Mov Disord"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2012.07.012","article-title":"Foveal vision is impaired in Parkinson\u2019s disease","volume":"19","author":"Bodis-Wollner","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"B125","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/a0031225","article-title":"Fovea and foveation in Parkinson\u2019s disease","volume":"127","author":"Bodis-Wollner","year":"2013","journal-title":"Behav Neurosci"},{"key":"B126","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00702-012-0909-5","article-title":"Remodeling of the fovea in Parkinson disease","volume":"120","author":"Spund","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"key":"B127","first-page":"359","article-title":"Huntington\u2019s disease: pathogenesis, diagnosis and treatment","volume":"19","author":"Purdon","year":"1994","journal-title":"J Psychiatry Neurosci"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4238\/gmr16029648","article-title":"REVIEW-ARTICLE intermediate alleles of Huntington\u2019s disease HTT gene in different populations worldwide: a systematic review","volume":"16","author":"Apolinario","year":"2017","journal-title":"Genet Mol Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/s41598-017-01510-z","article-title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients","volume":"7","author":"Neueder","year":"2017","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/hmg\/ddt176","article-title":"Dominant effects of the Huntington\u2019s disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy","volume":"22","author":"Lee","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B132","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/mds.23849","article-title":"CAG repeat size in the normal HTT allele and age of onset in Huntington\u2019s disease","volume":"26","author":"Aziz","year":"2011","journal-title":"Mov Disord"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","article-title":"Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression","volume":"262","author":"Kersten","year":"2015","journal-title":"J Neurol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mds.26486","article-title":"Spectral-domain optical coherence tomography as a potential biomarker in Huntington\u2019s disease","volume":"31","author":"Andrade","year":"2016","journal-title":"Mov Disord"},{"key":"B135","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann Neurol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","article-title":"Onset of multiple sclerosis associated with anti-TNF therapy","volume":"57","author":"Sicotte","year":"2001","journal-title":"Neurology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","article-title":"Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/brain\/awq133","article-title":"Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology","volume":"133","author":"Calabresi","year":"2010","journal-title":"Brain"},{"key":"B139","doi-asserted-by":"publisher","first-page":"iii11","DOI":"10.1136\/jnnp.2005.073213","article-title":"Imaging in multiple sclerosis","volume":"76","author":"Trip","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B140","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1212\/WNL.0b013e31827deb39","article-title":"Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential","volume":"80","author":"Klistorner","year":"2013","journal-title":"Neurology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/brain\/awm285","article-title":"An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography","volume":"131","author":"Henderson","year":"2008","journal-title":"Brain"},{"key":"B142","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1177\/1352458511418630","article-title":"Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness","volume":"17","author":"Saidha","year":"2011","journal-title":"Mult Scler"},{"key":"B144","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e193; author reply e194","DOI":"10.1093\/brain\/awr095","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography","volume":"134","author":"Brandt","year":"2011","journal-title":"Brain"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1212\/01.wnl.0000294876.49861.dc","article-title":"Optical coherence tomography and disease subtype in multiple sclerosis","volume":"69","author":"Pulicken","year":"2007","journal-title":"Neurology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/ene.12070","article-title":"Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis","volume":"20","author":"Young","year":"2013","journal-title":"Eur J Neurol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jns.2009.02.354","article-title":"Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes","volume":"281","author":"Costello","year":"2009","journal-title":"J Neurol Sci"},{"key":"B149","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.1073\/pnas.0405146101","article-title":"Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration","volume":"101","author":"Hahn","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B150","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-319-17121-0_17","article-title":"beta-Amyloidopathy in the pathogenesis of age-related macular degeneration in correlation with neurodegenerative diseases","volume":"854","author":"Ermilov","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B152","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00592-017-0996-8","article-title":"Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy","volume":"54","author":"Carnevali","year":"2017","journal-title":"Acta Diabetol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/IAE.0b013e318276e11e","article-title":"Multimodal evaluation of foveal sparing in patients with geographicatrophy due to age-related macular degeneration","volume":"33","author":"Forte","year":"2013","journal-title":"Retina"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2147\/OPTH.S92359","article-title":"Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects","volume":"9","author":"Danis","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1484","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3233\/JAD-150238","article-title":"Alzheimer\u2019s disease cerebrospinal fluid and neuroimaging biomarkers: diagnostic accuracy and relationship to drug efficacy","volume":"46","author":"Khan","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B158","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1517\/13543776.2015.1007953","article-title":"Compounds for imaging amyloid-beta deposits in an Alzheimer\u2019s brain: a patent review","volume":"25","author":"Tu","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"B159","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/brain\/awm191","article-title":"PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis","volume":"130","author":"Lockhart","year":"2007","journal-title":"Brain"},{"key":"B160","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00280-006-0362-y","article-title":"Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors","volume":"60","author":"Lockhart","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2967\/jnumed.106.037762","article-title":"Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer\u2019s disease","volume":"48","author":"Ng","year":"2007","journal-title":"J Nucl Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00701\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T15:57:38Z","timestamp":1526399858000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00701\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":161,"alternative-id":["10.3389\/fneur.2017.00701"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00701","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"article-number":"701"}}